|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
WO1984003506A1
(en)
|
1983-03-08 |
1984-09-13 |
Commw Serum Lab Commission |
Antigenically active amino acid sequences
|
|
NZ207394A
(en)
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
|
US4863940A
(en)
|
1984-07-26 |
1989-09-05 |
Rohm And Haas |
N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5571689A
(en)
|
1988-06-16 |
1996-11-05 |
Washington University |
Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
WO1990007329A1
(en)
|
1989-01-06 |
1990-07-12 |
The Regents Of The University Of California |
Selection method for pharmacologically active compounds
|
|
EP0594600A1
(en)
|
1990-03-13 |
1994-05-04 |
FISONS plc |
Immunosuppressive macrocyclic compounds
|
|
EP0558671B1
(en)
|
1990-11-21 |
1999-01-27 |
Iterex Pharmaceuticals Ltd. Partnership |
Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
|
|
ES2113940T3
(es)
|
1990-12-03 |
1998-05-16 |
Genentech Inc |
Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1992013549A1
(en)
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
SE9102462D0
(sv)
|
1991-08-28 |
1991-08-28 |
Astra Ab |
New isosteric peptides
|
|
ATE140449T1
(de)
|
1991-10-07 |
1996-08-15 |
Hoechst Ag |
Verfahren zur diastereoselektiven reduktiven pinakol-kupplung von homochiralen alpha- aminoaldehyden
|
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
EP0650368A1
(en)
|
1992-06-24 |
1995-05-03 |
Cortex Pharmaceuticals, Inc. |
Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
|
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
|
AU7922794A
(en)
|
1993-10-07 |
1995-05-01 |
Du Pont Merck Pharmaceutical Company, The |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
|
DE69637307T2
(de)
|
1995-11-28 |
2008-02-28 |
Cephalon, Inc. |
Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer
|
|
DE19642591A1
(de)
|
1996-10-15 |
1998-04-16 |
Basf Ag |
Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
|
|
WO1998021186A1
(en)
|
1996-11-13 |
1998-05-22 |
Cephalon, Inc. |
Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
|
|
DE19648793A1
(de)
|
1996-11-26 |
1998-05-28 |
Basf Ag |
Neue Benzamide und deren Anwendung
|
|
US5952322A
(en)
|
1996-12-05 |
1999-09-14 |
Pfizer Inc. |
Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
|
|
DE19650975A1
(de)
|
1996-12-09 |
1998-06-10 |
Basf Ag |
Neue heterocyclisch substituierte Benzamide und deren Anwendung
|
|
ES2202663T3
(es)
|
1996-12-11 |
2004-04-01 |
ABBOTT GMBH & CO. KG |
Cetobenzamidas como inhibidores de calpaina.
|
|
ES2222576T3
(es)
*
|
1997-03-14 |
2005-02-01 |
Smithkline Beecham Corporation |
Nueva quinolina- y naftalenocarboxamidas, composiciones farmaceuticas y procedimientos que inhiben el calpain.
|
|
JP4467648B2
(ja)
*
|
1997-03-14 |
2010-05-26 |
スミスクライン・ビーチャム・コーポレイション |
新規インドールカルボキサミド、医薬組成物およびカルパインの阻害方法
|
|
US6150378A
(en)
|
1997-10-07 |
2000-11-21 |
Cephalon, Inc. |
Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6083944A
(en)
|
1997-10-07 |
2000-07-04 |
Cephalon, Inc. |
Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
AU2960599A
(en)
|
1998-03-30 |
1999-10-18 |
Akira Karasawa |
Quinazoline derivatives
|
|
BR9909773A
(pt)
*
|
1998-04-20 |
2000-12-19 |
Basf Ag |
Amida heterociclicamente substituìda, uso da mesma, e, preparação farmacêutica para uso oral, parenteral e intraperitoneal
|
|
CA2328396C
(en)
|
1998-04-20 |
2009-02-10 |
Basf Aktiengesellschaft |
New substituted amides, their production and their use
|
|
DE19817459A1
(de)
*
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue heterozyklische substituierte Amide, Herstellung und Anwendung
|
|
KR20010042839A
(ko)
|
1998-04-20 |
2001-05-25 |
스타르크, 카르크 |
시스테인 프로테아제를 억제하는 효과를 나타내고헤테로시클릭 치환체가 있는 신규 아미드
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
DE19818614A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Amide, deren Herstellung und Anwendung
|
|
US6482832B1
(en)
|
1998-05-25 |
2002-11-19 |
Abbott Laboratories |
Heterocyclically substituted amides, their production and their use
|
|
US6335155B1
(en)
|
1998-06-26 |
2002-01-01 |
Sunesis Pharmaceuticals, Inc. |
Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
|
|
US6280946B2
(en)
|
1998-08-07 |
2001-08-28 |
Boston Probes, Inc. |
PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
|
|
JP2002533726A
(ja)
|
1998-12-28 |
2002-10-08 |
サネシス ファーマシューティカルス インコーポレイテッド |
結合のための小有機分子リガンドの同定
|
|
US6506733B1
(en)
|
1999-03-15 |
2003-01-14 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as protease inhibitors
|
|
EA200100972A1
(ru)
*
|
1999-03-15 |
2002-02-28 |
Аксис Фармасьютикалз, Инк. |
Новые соединения и композиции как ингибиторы протеаз
|
|
ATE336480T1
(de)
*
|
1999-03-16 |
2006-09-15 |
Cytovia Inc |
Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung
|
|
KR100718830B1
(ko)
|
1999-06-23 |
2007-05-17 |
사노피-아벤티스 도이칠란트 게엠베하 |
치환된 벤즈이미다졸 및 이의 제조방법
|
|
EP1254901A4
(en)
|
2000-01-26 |
2003-03-05 |
Ono Pharmaceutical Co |
5-CHAIN CYCLIC COMPOUNDS, CONTAINING NITROGEN, AND MEDICINAL PRODUCTS CONTAINING THE SAME AS ACTIVE INGREDIENTS
|
|
WO2001089584A2
(en)
|
2000-05-23 |
2001-11-29 |
Amersham Health As |
Contrast agents
|
|
US6582827B1
(en)
|
2000-11-27 |
2003-06-24 |
The Trustees Of Columbia University In The City Of New York |
Specialized substrates for use in sequential lateral solidification processing
|
|
DE10114762A1
(de)
|
2001-03-26 |
2002-10-02 |
Knoll Gmbh |
Verwendung von Cysteinprotease-Inhibitoren
|
|
ES2386775T3
(es)
|
2001-07-23 |
2012-08-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Procedimientos y composiciones para la inhibición mediada por ARNi de la expresión génica en mamíferos
|
|
US6878743B2
(en)
|
2001-09-18 |
2005-04-12 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
US20030167490A1
(en)
|
2001-11-26 |
2003-09-04 |
Hunter Craig P. |
Gene silencing by systemic RNA interference
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
WO2003064440A1
(de)
|
2002-01-31 |
2003-08-07 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Verbindungen, die faktor xa-aktivät inhibieren
|
|
CA2483998C
(en)
|
2002-04-25 |
2012-05-29 |
Ono Pharmaceutical Co., Ltd. |
Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
|
|
US7122580B2
(en)
|
2002-08-09 |
2006-10-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
|
SG159388A1
(en)
|
2003-01-08 |
2010-03-30 |
Chiron Corp |
Antibacterial agents
|
|
US20040242542A1
(en)
|
2003-03-25 |
2004-12-02 |
The Regents Of The University Of California |
Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders
|
|
WO2005000793A1
(ja)
|
2003-06-26 |
2005-01-06 |
Taisho Pharmaceutical Co., Ltd. |
２位置換シクロアルキルカルボン酸誘導体
|
|
EP1493739A1
(fr)
|
2003-07-03 |
2005-01-05 |
Warner-Lambert Company LLC |
Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2006528151A
(ja)
|
2003-07-21 |
2006-12-14 |
ノバルティス アクチエンゲゼルシャフト |
骨転移、腫瘍増殖および腫瘍誘発骨量減少の処置におけるカテプシンｋ阻害剤およびビスホスホネートの組み合わせ
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
CA2535337A1
(en)
|
2003-08-14 |
2005-03-03 |
Merck & Co., Inc. |
Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
US7632813B2
(en)
|
2004-04-26 |
2009-12-15 |
Ono Pharmaceutical Co., Ltd. |
Bone densifying agent characterized by use of cathepsin K inhibitor with PTH
|
|
BRPI0517567A
(pt)
|
2004-11-09 |
2008-06-17 |
Smithkline Beecham Corp |
composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto
|
|
US8257931B2
(en)
|
2005-01-21 |
2012-09-04 |
President And Fellows Of Harvard College |
Regulation of protein synthesis
|
|
US20080311036A1
(en)
*
|
2005-05-11 |
2008-12-18 |
University Of Florida Research Foundation, Inc. |
Imaging of Neural and Organ Injury or Damage
|
|
EP1915382A2
(en)
|
2005-08-01 |
2008-04-30 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
EP1968568A4
(en)
|
2005-12-22 |
2011-04-13 |
Glaxosmithkline Llc |
HEMMER OF NUTS ACTIVITY
|
|
WO2007081530A2
(en)
|
2006-01-03 |
2007-07-19 |
Med Institute, Inc. |
Endoluminal medical device for local delivery of cathepsin inhibitors
|
|
JP2009524681A
(ja)
|
2006-01-27 |
2009-07-02 |
フェノミックス コーポレーション |
Ｃ型肝炎ウイルスセリンプロテアーゼインヒビターおよびそのための使用
|
|
EP1983828A2
(en)
|
2006-02-16 |
2008-10-29 |
Sma Foundation |
Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
|
|
WO2007109080A2
(en)
|
2006-03-16 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
|
US20080045521A1
(en)
|
2006-06-09 |
2008-02-21 |
Astrazeneca Ab |
Phenylalanine derivatives
|
|
US8710178B2
(en)
|
2006-10-18 |
2014-04-29 |
Lincoln University |
Macrocyclic cysteine protease inhibitors and compositions thereof
|
|
PT2439205E
(pt)
*
|
2006-12-29 |
2015-07-16 |
Abbvie Deutschland |
Compostos de carboxamida e seus usos como inibidores de calpaína
|
|
WO2008106058A2
(en)
|
2007-02-27 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
CA2934114A1
(en)
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
TWI453019B
(zh)
|
2007-12-28 |
2014-09-21 |
Abbvie Deutschland |
甲醯胺化合物
|
|
WO2010023609A1
(en)
|
2008-08-25 |
2010-03-04 |
Piramal Life Sciences Limited |
Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors
|
|
JP5583694B2
(ja)
|
2009-01-05 |
2014-09-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体を調節するピロリジン化合物
|
|
GB2467561A
(en)
|
2009-02-06 |
2010-08-11 |
Summit Corp Plc |
Dual calpain-ROS inhibitors
|
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
|
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
|
US9051304B2
(en)
|
2009-12-22 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
US8598211B2
(en)
|
2009-12-22 |
2013-12-03 |
Abbvie Inc. |
Carboxamide compounds and their use as calpain inhibitors IV
|
|
AU2010339456A1
(en)
|
2009-12-30 |
2012-07-05 |
Celgene Avilomics Research, Inc. |
Ligand-directed covalent modification of protein
|
|
US20130079364A1
(en)
|
2010-04-21 |
2013-03-28 |
Signature Therapeutics, Inc. |
Peripheral Opioid Agonists and Peripheral Opioid Antagonists
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
WO2011159781A2
(en)
|
2010-06-17 |
2011-12-22 |
Senomyx, Inc. |
Bitter taste modulators
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012021788A2
(en)
|
2010-08-13 |
2012-02-16 |
Banyan Biomarkers |
Dipeptide calpain inhibitors
|
|
ES2646834T3
(es)
|
2010-08-20 |
2017-12-18 |
Amira Pharmaceuticals, Inc. |
Inhibidores de autotaxina y usos de los mismos
|
|
US20120095211A1
(en)
|
2010-09-22 |
2012-04-19 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
|
US9062027B2
(en)
|
2010-12-09 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
AU2012225337B2
(en)
|
2011-03-09 |
2016-04-28 |
Signature Therapeutics, Inc. |
Active agent prodrugs with heterocyclic linkers
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
EP2697246B1
(en)
|
2011-04-15 |
2018-03-07 |
Genesis Technologies Limited |
Selective cysteine protease inhibitors and uses thereof
|
|
EP2753334B1
(en)
|
2011-08-30 |
2022-10-19 |
Trustees Of Tufts College |
Fap-activated proteasome inhibitors for treating solid tumors
|
|
RU2014123784A
(ru)
|
2011-11-25 |
2015-12-27 |
Ф. Хоффманн-Ля Рош Аг |
Новые производные пирролидина в качестве ингибиторов катепсина
|
|
JP6068505B2
(ja)
|
2012-01-11 |
2017-01-25 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
プロテアーゼ阻害剤としてのマクロ環式アミド
|
|
SG11201406345XA
(en)
*
|
2012-04-03 |
2014-11-27 |
Abbvie Deutschland |
Carboxamide compounds and their use as calpain inhibitors v
|
|
CA2872147A1
(en)
|
2012-05-02 |
2013-11-07 |
Kansas State University Research Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses
|
|
US20150299250A1
(en)
|
2012-11-16 |
2015-10-22 |
Adelaide Research & Innovation Pty Ltd |
Macrocyclic compounds and uses thereof
|
|
EP3016951B1
(en)
|
2013-07-02 |
2017-05-31 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|
|
AR098414A1
(es)
*
|
2013-11-14 |
2016-05-26 |
Bristol Myers Squibb Co |
PIPERAZINAS DE PIRAZOLO SUSTITUIDO COMO INHIBIDORES DE CASEÍNA QUINASA 1 d/e
|
|
US20170088878A1
(en)
|
2014-02-19 |
2017-03-30 |
Eth Zurich |
Method for the generation of chemical libraries
|
|
JP2017508810A
(ja)
*
|
2014-03-21 |
2017-03-30 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
シアノ置換イミダゾ［１，２−ａ］ピリジンカルボキサミドおよびその使用
|
|
US10392422B2
(en)
|
2014-05-20 |
2019-08-27 |
Rqx Pharmaceuticals, Inc. |
Macrocyclic broad spectrum antibiotics
|
|
WO2015196086A1
(en)
*
|
2014-06-20 |
2015-12-23 |
The University of Montana, Missoula, MT |
NOVEL INHIBITORS OF SYSTEM Xc(-)
|
|
WO2016027284A2
(en)
|
2014-08-22 |
2016-02-25 |
Alkem Laboratories Ltd. |
Piperidine ureas as cathepsin cysteine protease inhibitors
|
|
EP3189047B1
(en)
|
2014-09-04 |
2018-12-26 |
Bristol-Myers Squibb Company |
Diamide macrocycles that are fxia inhibitors
|
|
US11219670B2
(en)
|
2014-09-05 |
2022-01-11 |
The Johns Hopkins University |
Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
MX2017017097A
(es)
|
2015-07-02 |
2018-05-23 |
Tp Therapeutics Inc |
Macrociclos diarílicos quirales como moduladores de proteínas quinasas.
|
|
CN108368110A
(zh)
*
|
2015-12-07 |
2018-08-03 |
普莱希科公司 |
用于激酶调节的化合物和方法以及其适应症
|
|
CN105669520B
(zh)
|
2016-01-12 |
2018-10-30 |
山东大学 |
含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
AU2017229591B2
(en)
|
2016-03-09 |
2021-08-19 |
Blade Therapeutics Pty Ltd |
Calpain modulators and methods of production and use thereof
|
|
PT3478284T
(pt)
|
2016-06-29 |
2023-12-18 |
Univ California |
Compostos e composições para o tratamento do cancro
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF
|
|
SG10201912574WA
(en)
|
2016-09-28 |
2020-02-27 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
|
CA3067063A1
(en)
|
2017-06-23 |
2018-12-27 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
SG11202008750XA
(en)
*
|
2018-03-28 |
2020-10-29 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
|
AU2019242595A1
(en)
|
2018-03-28 |
2020-11-19 |
Blade Therapeutics, Inc. |
Method of treating fibrotic disease
|
|
WO2019217465A1
(en)
|
2018-05-09 |
2019-11-14 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof background
|
|
AU2019295763A1
(en)
|
2018-06-28 |
2021-01-21 |
Blade Therapeutics, Inc. |
Methods of treating liver fibrosis using calpain inhibitors
|
|
WO2020006177A1
(en)
|
2018-06-29 |
2020-01-02 |
Blade Therapeutics, Inc. |
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|